In this study, we identified a mast cell subpopulation associated with resistance to neoadjuvant chemotherapy, characterized by low BTG2 expression, through scRNA sequencing of primary breast cancer samples and paired metastatic lymph nodes. This evidence concerns the gene BTG2 and breast carcinoma.